{
    "Trade/Device Name(s)": [
        "AutoSure Voice II Blood Glucose Monitoring System",
        "AutoSure Voice II Pro Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Apex BioTechnology Corp.",
    "510(k) Number": "K150396",
    "Predicate Device Reference 510(k) Number(s)": [
        "K102037"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "September 11, 2015",
    "Summary Letter Received Date": "September 14, 2015",
    "Submission Date": "October 12, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AutoSure Voice II Meter",
        "AutoSure Voice II Pro Meter"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for AutoSure Voice II and AutoSure Voice II Pro Blood Glucose Monitoring Systems for quantitative glucose measurement in capillary whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertips, forearm, or palm; AutoSure Voice II for single-patient home use, AutoSure Voice II Pro for multiple-patient professional use; includes voice functionality for visually impaired users; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}